Mark G. Foletta - 15 Jun 2026 Form 4 Insider Report for AMN HEALTHCARE SERVICES INC (AMN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Jun 2026, 07:31:58 UTC
Prior SEC filing
01 Jun 2026
Next SEC filing
04 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Mark G. Foletta

Key filing fact

Mark G. Foletta filed Form 4 for AMN HEALTHCARE SERVICES INC (AMN) on 17 Jun 2026.

Key facts

  • This page summarizes Mark G. Foletta's Form 4 filing for AMN HEALTHCARE SERVICES INC (AMN).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jun 2026, 07:31.

Change

  • Previous filing in this sequence was filed on 01 Jun 2026.
  • Current net transaction value: -$114,362.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001236389 Primary reporting owner

FOLETTA MARK G

Relationship
Director
Address
2999 OLYMPUS BOULEVARD, SUITE 500, DALLAS
Signature
/s/ Whitney M. Laughlin, as attorney-in-fact on behalf of Mark G. Foletta
Signature date
16 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMN transaction

Common Stock

Sale

Transaction value
$52,224
Shares
-1,681
Change %
-7.8%
Price
$31.07
Shares after
19,917
Date
15 Jun 2026
Ownership
by Trust
Footnotes
F1, F2, F3
AMN transaction

Common Stock

Sale

Transaction value
$62,138
Shares
-2,000
Change %
-10%
Price
$31.07
Shares after
17,917
Date
15 Jun 2026
Ownership
by Trust
Footnotes
F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The sale of 1,681 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026 (the "Trading Plan").

Footnote F2

The price reported in this row represents a weighted average price of $31.067 per share. These shares were sold in multiple transactions at prices ranging from $30.86 to $31.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F3

Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the Reporting Person is a trustee.

Footnote F4

The sale of 2,000 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026 (the "Trading Plan").

Footnote F5

The price reported in this row represents a weighted average price of $31.069 per share. These shares were sold in multiple transactions at prices ranging from $30.82 to $31.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .